OpenAlex
PricingAboutJobs
Log inGet started
Work

Evaluation of the efficacy, safety and glycaemic effects of evolocumab ( AMG 145) in hypercholesterolaemic patients stratified by glycaemic status and metabolic syndrome

HTML

Year: 2016
Type: article
Source: Diabetes Obesity and Metabolism
DOI: 10.1111/dom.12788
Authors: Dirk J. Blom, Michael J. Koren, Eli Roth, Maria Laura Monsalvo, C. Stephen Djedjos, Patric Nelson, Mary Elliott, Scott M. Wasserman, Christie M. Ballantyne, Rury R. Holman
Institutions: University of Cape Town, Jacksonville Center for Clinical Research, Sterling Research Group, Amgen (United States), Gilead Sciences (United States), Ionis Pharmaceuticals (United States), Amgen (United Kingdom), Houston Methodist, Baylor College of Medicine, University of Oxford, Oxford Centre for Diabetes, Endocrinology and Metabolism
Language: English

Topic: Lipoproteins and Cardiovascular Health
Subfield: Cardiology and Cardiovascular Medicine
Field: Medicine
Domain: Health Sciences
Keywords: evolocumab, PCSK9 inhibition, hypercholesterolemia, LDL cholesterol lowering, dysglycemia, type 2 diabetes, impaired fasting glucose, metabolic syndrome, new-onset diabetes, HbA1c, insulin resistance
SDG: Good health and well-being

Open Access status: closed

Funders: Amgen, Medpace
OpenAlex ID: W2522643247
FWCI: 7.008
Cites: 37
Cited by: 66
Related to: 10
OpenAlex
Nonprofit
Open DataOpen Data
Open Source
Product
Search
Compare
Pricing
Repositories
Unpaywall
Unsub
Developers
API docs
Data snapshot
Status
Source code
Organization
About
Team
Testimonials
Brand
Jobs
Community
Help center
Contact
Events
Blog
Mailing list
Supporters
Legal
Privacy
Accessibility
Terms
Security